Evidence for 1,25-Dihydroxyvitamin D3-Independent Transactivation by the Vitamin D Receptor

    Tara I. Ellison, Richard L. Eckert, Paul N. MacDonald
    New to cholecalciferol? There is a guide in the encyclopedia. Read the guide →
    Studysummary This study found that vitamin D receptor activation in primary keratinocytes can occur independently of the 1,25-dihydroxyvitamin D<sub>3</sub> ligand, likely through interaction with retinoid X receptors.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    The study provided evidence that the Vitamin D Receptor (VDR) could activate transcription independently of its ligand, 1,25-Dihydroxyvitamin D3 (1,25(OH)2D3), specifically in primary keratinocytes. This was demonstrated by the activation of the 24-hydroxylase promoter without 1,25(OH)2D3. The findings suggested that VDR might interact with other ligands or undergo modifications such as phosphorylation to exert its effects. This ligand-independent activity was unique to keratinocytes and selective for certain promoters, indicating a potential for targeted therapeutic strategies in skin disorders like psoriasis and skin cancer without causing hypercalcemia. The study also highlighted the importance of VDR-RXR heterodimerization in this process.
    Discuss this study in the Community →

    Research cited in this study

    7 / 7 results